S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer
OncLive® On Air
00:00
Choosing between ADCs and QoL tradeoffs
Marlene and Heather stress patient preference, toxicity profiles, schedules, and supportive care access when selecting ADCs.
Play episode from 23:36
Transcript
